penn medicine
penn surgery
penn surgery home penn surgery clinical penn surgery education penn surgery research penn surgery administration

Thomas J. Guzzo, MD, MPH
Urology

 
  • Profile Home
  • Appointments
  • Education
  • Memberships
  • Research
  • Publications

Administrative/Clinical Offices:
Perelman Center for Advanced Medicine
West Pavilion, 3rd Floor
3400 Civic Center Boulevard
Philadelphia, PA 19104
Administrative Assistant: Kamah Scott
Administrative Telephone: 215-662-2891
Administrative Fax: 215-662-3955

Contact Information (internal use only)

thomas.guzzo@uphs.upenn.edu

 

Dr. Guzzo is a graduate of Temple University School of Medicine. He completed his general surgery internship and urology residency at the Hospital of the University of Pennsylvania. Dr. Guzzo completed a two year fellowship at the James Buchanan Brady Urological Institute of the Johns Hopkins Hospital in urologic oncology. During his fellowship he also earned a Masters in Public Health from the Johns Hopkins Bloomberg School of Public Health. He is extensively trained in the treatment of all aspects of urologic malignancies including open, laparoscopic, endoscopic and robotic surgical treatment for such malignancies.

Dr. Guzzo’s clinical areas of expertise include the surgical treatment of prostate, bladder, kidney and testicular cancer. There are many options for patients with urologic cancer and because Dr. Guzzo’s expertise includes open, endoscopic, laparoscopic and robotic surgery he is equipped to individualize treatment options for patients with a wide range of urologic malignancies. Additionally, Dr. Guzzo is a collaborator with the proton therapy program at the University of Pennsylvania.

Dr. Guzzo is a member of the American Urologic Association and the American College of Surgeons. He is actively involved in urologic research having published over 40 peer-reviewed manuscripts and five book chapters. Additionally, he has presented multiple clinical research abstracts at both national and international meetings. He was the recipient of the prestigious Prostate Cancer Foundation Young Investigator Award in 2009. Dr. Guzzo’s areas of research interest include patient reported outcomes and quality of life after urologic cancer surgery.

 
Faculty Appointments
2007 - 2009 Clinical Instructor in Urology
James Buchanan Brady Urological Institute of Johns Hopkins University, Baltimore, Maryland
 
2009 - present Assistant Professor of Urology in Surgery at HUP
Perelman School of Medicine
Philadelphia, Pennsylvania
 
Hospital and Administrative Appointments
2009 - present Attending Urologist
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
 
2009 - present Active Urologist
Penn Presbyterian Medical Center
Philadelphia, Pennsylvania
 
2008 - present Active Urologist
Pennsylvania Hospital
Philadelphia, Pennsylvania
 
2009 - present Course Director, Urology Medical Student Education
 
2009 - present Grand Rounds Coordinator, Division of Urology
   
2009 - present Course Director, Urology Medical Student Education
   
2011 - present  Associate Director of the Residency Program in Urology
   
2011 - present  Committee member, IRB#2
   
2011 - present  Committee member, Medical Legal Committee, HUP
   
2012 - present 

Committee member, HUP Robotic Surgery Committee

 
Education/Training
1993 - 1997 B.S. Ursinus College
Collegeville, Pennsylvania (Biology)
 
1998 - 2002 M.D. Temple University School of Medicine
Philadelphia, Pennsylvania
 
2007 - 2009 MPH Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
 
Postgraduate Training and Fellowship Appointments
2002 - 2003 Intern in General Surgery
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania
 
2003 - 2007

Resident in Urology
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania

 
2007 - 2009 Fellow in Urologic Oncology, James Buchanan Brady Urological Institute of Johns Hopkins University
Baltimore, Maryland
 
Memberships/Societies
 
National/International Societies
  • American Urologic Association
  • American College of Surgeons
  • American Medical Association
  • Alpha Omega Alpha
Local/Regional Societies
  • Mid-Atlantic Section, American Urologic Association
  • Philadelphia Urologic Society
Scientific Committees
  • Scientific Advisory Board, Prostate Cancer Foundation
 
Research
 
June 2009 Prostate Cancer Foundation Young Investigator Award
 
Project:
The goal of this project is to study both functional and oncologic outcomes in patients undergoing prostate cancer treatments.
 
Support:
3 years
 
Publications
 
Research Publications, Peer Reviewed
  1. Guzzo T, Gerstein M. Mydlo JH. Granulosa cell tumor of the contralateral testis in a man with a history of cryptorchism. Urologia Internationalis 72(1):85-87, 2004.
  2. Zuniga ZV, Guzzo T, Docimo SG. Bilateral single system ectopic ureters in a male infant. Urology 66(2):432, 2005 Aug.
  3. Guzzo TJ, Vira M, Hwang WT, D'amico A, Tomaszewski J, Whittington R, Wein AJ, Van Arsdalen K, Malkowicz SB. Impact of multiple biopsy cores on predicting final tumor volume in prostate cancer detected by a single microscopic focus of cancer on biopsy. Urology 66(2):361-365, Aug. 2005.
  4. Guzzo TJ, Vira M, Wang Y, Tomaszewski J, D'amico A, Wein AJ, Malkowicz SB. Preoperative parameters, including percent positive biopsy, in predicting seminal vesicle involvement in patients with prostate cancer. Journal of Urology 175(2):518-522, Feb. 2006.
  5. Kutikov A, Guzzo TJ, Canter DJ, Casale P. Initial experience with laparoscopic transvesical ureteral reimplantation at the Children's Hospital of Philadelphia. Journal of Urology 176(5):2222-2226, Nov. 2006.
  6. Kutikov A, Nguyen M, Guzzo T, Canter D, Casale P. Robot assisted pyeloplasty in the infant: Lessons learned. Journal of Urology 176(5):2237-2240, Nov. 2006.
  7. Guzzo TJ, Vira MA, Neway W, Hwang WT, Tomaszewski J, Van Arsdalen K, Wein AJ, Malkowicz SB. Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy. Urology 69(6):1147-1151, June 2007.
  8. Kutikov A, Nguyen M, Guzzo T, Canter D, Casale P. Laparoscopic and robotic complex upper-tract reconstruction in children with a duplex collecting system. Journal of Endourology 21(6):621-624, June 2007.
  9. Guzzo TJ, Levin BM, Lee R, Guo M, Chen Z, Whittington R, Tomaszewski J, Malkowicz SB. Relationship of biochemical outcome to percentage of positive biopsies in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy. Urology 71(4):723-727, Apr. 2008.
  10. Vira MA, Guzzo T, Heitjan DF, Tomaszewski JE, D'Amico A, Wein AJ, Malkowicz SB. Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known? BJU International 101(10):1232-1236, May 2008.
  11. Resnick MJ, Canter D, Brucker BM, Kutikov A, Guzzo TJ, Wein AJ. Medscape. A case of synchronous bilateral testicular seminoma. Nature Clinical Practice Urology 5(7):397-401, July 2008.
  12. Canter D, Guzzo TJ, Resnick MJ, Brucker B, Vira M, Chen Z, Tomaszewski J, Van Arsdalen K, Wein AJ, Malkowicz SB. Hydronephrosis is he is is he is an independent predictor of poor clinical outcome in patients treated for muscle-invasive transitional cell carcinoma with radical cystectomy. Urology 72(2):379-383, Aug. 2008.
  13. Guzzo TJ, Kutikov A, Canter DJ, Tomaszewski JE, Magerfleish L, Van Arsdalen K, Wein AJ, Malkowicz SB. The clinical and pathological history of prostate cancer progression in men with a prior history of high grade prostatic intraepithelial neoplasia. Canadian Journal of Urology 15(4):4174-4179, Aug. 2008.
  14. Kutikov A, Van Arsdalen KN, Gershman B, Fossett LK, Guzzo TJ, Wein AJ, Malkowicz SB. Enucleation of renal cell carcinoma with ablation of the tumour base. BJU International 102(6):688-691, Sept. 2008.
  15. Canter D, Guzzo T, Resnick M, Magerfleisch L, Sonnad S, Bergey M, Tomazewski J, Vaughn D, Van Arsdalen K, Malkowicz B. The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis. BJU International 102(8):952-957, Sept. 2008.
  16. Guzzo TJ, Schaeffer EM, Allaf ME. Laparoscopic radical nephroureterectomy with en-bloc distal ureteral and bladder cuff excision using a single position pneumovesicum method. Urology 72(4):850-852, Oct. 2008.
  17. Bivalacqua TJ, Guzzo TJ, Schaeffer EM, Gebska MA, Champion HC, Burnett AL, Gonzalgo ML. Application of Evicel to cavernous nerves of the rat does not influence erectile function in vivo. Urology 72(5):1169-1173, Nov. 2008.
  18. Guzzo TJ, Rogers CG, Deng CY, Bivalacqua TJ, Palapattu GS, Bastian PJ, Eisenberger MA, Schoenberg MP, Gonzalgo ML. Outcomes of patients after aborted radical cystectomy for intraoperative findings of metastatic disease. BJU International 102(11):1539-1543, Dec. 2008.
  19. Guzzo TJ, Pierorazio PM, Schaeffer EM, Fishman EK, Allaf ME. The accuracy of multidetector computerized tomography for evaluating tumor thrombus in patients with renal cell carcinoma. Journal of Urology 181(2):486-491, Feb. 2009.
  20. Guzzo TJ, Allaf ME. Laparoscopic retroperitoneal lymph node dissection for stage I and II nonseminomatous germ-cell tumors. Therapeutic Advanced Urology 2009 (in press).
  21. Mayer WA, Resnick MJ Canter D, Ramchandani P, Kutikov A, Harryhill JF, Carpiniello VL, Guzzo TJ. Synchronous metastatic renal cell carcinoma to the genitourinary tract: Two rare case reports and review of the literature. Canadian Journal of Urology 16(2):4611-4, Apr. 2009.
  22. Alphs HH, Miles-Thomas J, Attenello F, Taube JM, Fonseca G, Guzzo TJ. Presentation and management of a patient with subcutaneous metastatic transitional cell carcinoma of the bladder. Nature Clinical Practice Urology 2009 (in press).
  23. Guzzo TJ, Pollock RA, Forney A, Aggarwal P, Matlaga BR, Allaf ME. Safety and efficacy of a surgeon prepared gelatin hemostatic agent compared to FloSeal for hemostasis in laparoscopic partial nephrectomy. Journal of Endourology 23(2):279-82, Feb. 2009.
  24. Resnick MJ, Canter DJ, Guzzo TJ, Brucker BM, Bergey MR, Sonnad S. Does race impact postoperative outcomes in low risk prostate cancer patients who undergo radical prostatectomy? Urology 2009 (in press).
  25. Rais-Bahrami S, Guzzo TJ, Jarrett TW, Kavoussi LR, Allaf ME. Incidentally discovered renal masses: Oncologic and perioperative outcomes in patients with delayed surgical intervention. BJU International 2009 (in press).
  26. Guzzo TJ, Gonzalgo ML. Robotic surgical training of the urologic oncologist. Urologic Oncology 27(2):214-7, Mar-Apr. 2009.
  27. Guzzo TJ, Allaf ME, McNeil BK, Kavoussi LR, Pavlovich CP, Schaeffer EM. Perioperative outcomes in elderly patients undergoing laparoscopic renal procedures: A single institution experience. Urology 2009 (in press).
  28. Guzzo TJ, Schaeffer EM, McNeil BK, Chan DY, Allaf ME. Laparoscopic radical nephrectomy for patients with T3b renal cell carcinoma: The Johns Hopkins experience. Journal of Endourology 2009 (in press).
  29. Bivalacqua TJ, Bagga HS, Patil K, Magheli A, Taube JM, Guzzo TJ, Gonzalgo ML. Urethral Carcinosarcoma from bladder carcinosarcomatous lesions: Analysis of clinicopathologic features. Canadian Journal of Urology 16(1):4512-5, Feb. 2009.
  30. Canter D, Guzzo TJ, Resnick MJ, Bergey MR, Sonnad SS, Tomaszewski J, VanArsdalen K, Malkowicz SB. A thorough pelvic lymph node dissection in presence of positive margins associated with better clinical outcomes in radical cystectomy patients. Urology (in press).
  31. Guzzo TJ, Bivalacqua TJ, Pierorazio PM, Varkarakis J, Schaeffer EM, Allaf ME: Xanthogranulomatous pyelonephritis: presentation and management in the laparoscopic era. British Journal of Urology 2009 (in press).
  32. Guzzo TJ, Magheli A, Bivalacqua TJ, Nielsen ME, Attenello FJ, Schoenberg MP and Gonzalgo ML: Pathologic upstaging at the time of radical cystectomy is associated with worse recurrence free survival in patients with BCG-refractory bladder cancer. Urology 2009 (in press)
  33. Schaeffer EM, Guzzo TJ, Netto G, Kouzi R, Furge KA, Westphal M, Dykema K, Yang XJ, Zhou M, Argani P, The BT and Pavlovich CP: Renal medullary carcinoma: molecular, pathologic and clinical evidence for treatment with topoisomerase inhibiting therapy. British Journal of Urology 2009 (in press)
  34. Guzzo TJ, McNeil BK, Bivalacqua TJ, Elliott DJ, Sokoll LJ and Schoenberg MP: The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy. Urologic Oncology (In press).
  35. Resnick MJ, Canter DJ, Guzzo TJ, Magerfleisch L, Tomaszewski JE, Brucker BM, Bergey MR, Sonnad SS, Wein AJ and Malkowicz SB: Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: implications for adjuvant radiotherapy. BJU International (In press).
  36. Pierorazio PM, Guzzo TJ, Han M, Bivalacqua TJ, Epstein JI, Schaeffer EM, Schoenberg MP, Walsh PC and Partin AW: Long-term survival after radical prostatectomy for men with high Gleason sum in the pathological specimen. Urology 2010 (In press).
  37. Guzzo TJ, Dluzniewski P, Orosco R, Platz EA, Partin AW and Han M: Prediction of mortality following radical prostatectomy by Charlson comorbidity index. Urology 2010 (In press).
  38. Guzzo TJ, Gonzalgo ML and Allaf ME: Laparoscopic retroperitoneal lymph node dissection with therapeutic intent in men with clinical stage I nonseminomatous germ cell tumors. Journal of Endourology 2010 (In press).
  39. Pollock R, Mozer P, Guzzo TJ, Mark J, Matlaga B, Petrisor D, Vigaru B, Badaan S, Stoianovici D and Allaf ME: Future prospects in percutaneous ablative targeting: comparison of a computer-assisted navigation system and “AcuBot” robotic system. Journal of Endourology 2010 (In press).
  40. Sehgal SS, Wein AJ, Malkowicz SB and Guzzo TJ: Neuroendocrine tumor of the bladder: a case report and review of the literature. Reviews in Urology 2010 (In press).
  41. Resnick, MJ, Bergey M, Magerfleisch L, Tomaszewski JE, Malkowicz SB and Guzzo TJ: Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transurethral resection and radical cystectomy. BJU International (In press).
  42. Resnick MJ, Lee DJ, VanArsdalen K, Wein AJ, Tomaszewski JE, Malkowicz SB and Guzzo TJ: Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer. Urology 2009 (in press).
  43. Han M, Trock BJ, Partin AW, Humphreys EB, Bivalacqua TJ, Guzzo TJ and Walsh PC: The impact of preoperative erectile dysfunction on survival after radical prostatectomy. BJU International (In press).
  44. Bivalacqua TJ, Loeb S, Pierorazio PM, Schoenberg MP, Partin AW and Guzzo TJ: Is prostate specific antigen surveillance necessary in men with benign prostate pathology following radical cystoprostatectomy for bladder cancer? Urologia Internationalis (In Press).
  45. Magheli A, Gonzalgo ML, Su LM, Guzzo TJ, Netto G, Humphreys EB, Han M, Partin AW and Pavlovich CP: Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching. BJU International (In press).
  46. Guzzo TJ, Resnick MJ, Canter DJ, Balandra A, Bergey MR, Magerfleish L, Tomaszewski JE, Vaughn DJ and Malkowicz SB: Impact of adjuvant chemotherapy on patients with lymph node metastasis at the time of radical cystectomy. Canadian Journal of Urology 17(6): 5465-71, Dec. 2010.
  47. Wang H, Albadine R, Magheli A, Guzzo TJ, Ball MW, Hinz S, Schoenberg MP, Netto GJ and Gonzalgo ML: Increased EZH2 protein expression is associated with invasive urothelial carcinoma of the bladder.  Urologic Oncology (In Press)
  48. Guzzo TJ, Hockenberry BA, Mucksavage P, Bivalacqua TJ and Schoenberg MP: Smoking knowledge assessment and cessation trends in patients with bladder cancer. Urology (In press)
  49. Yeboa DN, Guzzo TJ, Mitra N, Christodouleas JP, Haas NB, Vapiwala N, Armstrong K and Bekelman JE: Prostate specific antigen surveillance among men with clinically localized prostate cancer who do not receive initial treatment. Urology (In press).
  50. Guzzo TJ, Resnick MJ, Canter DJ, Bivalacqua TJ, Rosen MA, Bergey MR, Magerfleisch L, Tomaszewski JE, Wein AJ and Malkowicz SB: Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance. Urologic Oncology (In press)
  51. Wehrenberg-Klee E, Clark TW, Malkowicz SB, Soulen MC, Wein AJ, Mondschein JI, VanArsdalen KV, Guzzo TJ, Stavropoulos SW: Impact on renal function of percutaneous thermal ablation of renal masses in patients with preexisting chronic kidney disease. J Vasc Interv Radiol (In press)
  52. Lotan Y, Amiel G, Boorjian SA, Clark PE, Droller M, Gingrich JR, Guzzo TJ, Inman BA, Kamat AM, Karsh L, Nielsen ME, Smith ND, Shariat SF, Svatek RS and Taylor JM: Comprehensive handbook for developing a bladder cancer cystectomy database. Urologic Oncology (In Press)
  53. Swisher-McClure S, Pollack CE, Christodouleas JP, Guzzo TJ, Haas NB, Vapiwala N and Bekelman JE: Variation in us of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys (In press)
  54. Mucksavage P, Ramchandani P, Malkowicz SB and Guzzo TJ: Is ultrasound imaging inferior to computed tomography or magnetic resonance imaging in evaluating renal mass size? Urology (In press)
  55. Mullins JK, Guzzo TJ, Ball MW, Pierorazio PM, Eifler J, Jarrett TW, Schoenberg MP and Bivalacqua TJ: Ureteral stents placed at the time of urinary diversion decreases postoperative morbidity. Urol Int (In press)
  56. Jang JW, Hwang WT, Guzzo TJ, Wein AJ, Haas NB, Both S and Vapiwala N: Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA. Int J Radiat Oncol Biol Phys (In Press)
  57. Nielsen ME, Smith AB, Pruthi RS, Guzzo TJ, Amiel G, Shore N and Lotan Y: Reported use of intravesical therapy for non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Advocacy Network (BCAN) survey. BJU Int (In press)
  58. Weiss BE, Wein AJ, Malkowicz SB and Guzzo TJ: Comparison of prostate volume measured by transrectal ultrasound and magnetic resonance imaging: is transrectal ultrasound suitable to determine which patients should undergo active surveillance? Urol Oncol (In press)
  59. Baumann BC, Guzzo TJ, He J, Keefe SM, Tucker K, Bekelman JE, Hwang WE, Vaughn DJ, Malkowicz SB and Christodouleas JP: A novel risk stratification to predict local-regional failures in urothelial carcinoma of the bladder after radical cystectomy. Int J Radiat Oncol (In press)
  60. Baumann BC, Guzzo TJ, He J, Vaughn DJ, Keefe SM, Vapiwala N, Deville C, Bekelman JE, Tucker K, Hwang WT, Malkowicz SB and Christodouleas JP: Bladder cancer patterns of pelvic failure: implications for adjuvant radiation therapy. Int J Radiat Oncol Biol Phys (In press)
  61. Goldsmith B, Tucker K, Conway RG, He J, Guzzo TJ, Bekelman J, Deville C, Vapiwala N, Malkowicz SB and Christodouleas J: Discordance between preoperative and postoperative bladder cancer location: implications for partial-bladder radiation. . Int J Radiat Oncol Biol Phys (In press)
Reviews in Peer Reviewed Research Publications
  1. Kutikov A, Guzzo TJ, Malkowicz SB. Clinical approach to the prostate: an update. [Review] Radiologic Clinics of North America 44(5):649-663, vii, Sept. 2006.
  2. Kasturi S, Kutikov A, Guzzo TJ, Smith AL, Wein AJ. Modern management of pheochromocytoma. [Review] Nature Clinical Practice Urology 4(11):630-633, Nov. 2007.
  3. Guzzo TJ, Bivalacqua TJ, Schoenberg MP. Bladder cancer and the aluminium industry: A review. [Review] BJU International 102(9):1058-1060, Nov. 2008.
  4. Guzzo TJ and Allaf ME: Laparoscopic retroperitoneal lymph node dissection for stage I and II nonseminomatous germ-cell tumors. Therapeutic Advances in Urology (In Press).
  5. Graves R, Laryngakis N, Malkowicz SB, Guzzo TJ: Therapeutic options for men with castrate-resistant prostate cancer. Annals of Urology (In Press).
  6. Guzzo TJ and Drach GW: Major urologic problems in geriatrics: assessment and management. Med Clin North Am 95(1): 253-64, Jan. 2011.
  7. Resnick MJ and Guzzo TJ: Bladder cancer: Improvements in clinical staging of muscle-invasive bladder cancer. Nat Rev Urol (In Press)
  8. Laryngakis NA, VanArsdalen KN, Guzzo TJ and Malkowicz SB: Tumor enucleation: a safe alternative for renal cell carcinoma. Expert Rev Anticancer Ther 11(6): 893-9, 2011.
  9. Pietzak EJ and Guzzo TJ: Advancements in laparoscopic partial nephrectomy: expanding the feasibility of nephron-sparing. Advances in Urology (In press)
  10. Laryngakis NA and Guzzo TJ: Tumor enucleation for small renal masses. Current Opinion in Urology (In press)
Abstracts
  1. Guzzo TJ, Vira MA, Neway W, Hwang WT, Tomaszewski JE, Van Arsdalen K, Wein AJ, Malkowicz SB. Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy. Abstract presented at Mid-Atlantic AUA Section Meeting, Washington, DC, Oct. 2006.
  2. Guzzo TJ, Kutikov A, Canter DJ, Tomaszewski JE, Magerfleish L, Van Arsdalen K, Wein AJ, Malkowicz SB. The antecedent history of high grade prostatic intraepithelial neoplasia in a radical prostatectomy cohort. Poster presented at AUA National Meeting, Anaheim, CA, May 2007.
  3. Guzzo TJ, Balandra A, Kutikov A, Canter DJ, Chen Z, Tomaszewski JE, Vaughn DJ, Malkowicz SB. Impact of adjuvant chemotherapy on patients with lymph node metastasis after radical cystectomy. Resident prize essay contest, Mid-Atlantic AUA Section Meeting, Bermuda, Oct. 2007.
  4. Canter DJ, Guzzo TJ, Resnick MJ, Vira M, Tomaszewski JE, VanArsdalen K, Wein AJ and Malkowicz SB: Hydronephrosis is an independent predictor of poor clinical outcomes in patients treated for muscle invasive bladder cancer. Resident prize essay contest, Mid-Atlantic AUA Section Meeting, Bermuda, Oct. 2007.
  5. Resnick MJ, Canter DJ, Guzzo TJ, Brucker BM, Bergey M, Sonnad S, Wein AJ and Malkowicz SB: Percent core involvement is an independent predictor of tumor volume at radical prostatectomy in low risk patients with one single core of prostate cancer on needle biopsy. Abstract presented at Mid-Atlantic AUA Section Meeting, Bermuda, Oct. 2007.
  6. Canter DJ, Guzzo TJ, Resnick MJ, Sonnad S, Bergey M, Tomaszewski J, VanArsdalen K, Malkowicz SB: The finding of positive surgical margins on pathological examination of radical cystectomy specimens portends a poor prognosis. Poster presented at AUA National Meeting, Orlando, FL May. 2008.
  7. Canter DJ, Guzzo TJ, Resnick MJ, Sonnad S, Bergey M, Tomaszewski J, VanArsdalen K, Malkowicz SB: The presence of lymphovascular invasion in radical cystectomy specimens for patients with transitional cell carcinoma independently predicts poor clinical outcomes. Poster presented at AUA National Meeting, Orlando, FL May. 2008.
  8. Brucker, BM, Bergey M, Resnick MJ, Sonnad S, Canter DJ, Guzzo TJ, Rebbeck TR, Wein AJ and Malkowicz SB: The impact of obesity on biochemical failure after radical prostatectomy in African-American and European American patients. Abstract presented at AUA National Meeting, Orlando, FL May. 2008.
  9. Resnick, MJ, Canter DJ, Brucker BM, Guzzo TJ, Bergey MR, Sonnad S, Wein AJ and Malkowicz SB: In patients eligible for active surveillance treated with radical prostatectomy, does race impact postoperative outcomes? Poster presented at Mid-Atlantic AUA Section Meeting, Cambridge, MD, Oct. 2008.
  10. Harris A, Huang W, Canter DJ, Guzzo TJ, Bergey M, Sonad S, Tomaszewski J, VanArsdalen K and Malkowicz SB: The significance of ureteral abnormalities at the time of radical cystectomy. Poster presented at Mid-Atlantic AUA Section Meeting, Cambridge, MD, Oct. 2008.
  11. Allaf ME, Guzzo TJ, Senger CM and Gonzalgo ML: Laproscopic retroperitoneal lymph node dissection with therapeutic intent: perioperative outocomes and early oncological results. Poster presented at Mid-Atlantic AUA Section Meeting, Cambridge, MD, Oct. 2008.
  12. Guzzo TJ, Bivalacqua TJ, Sokoll L, Schoenberg MP. Detection of circulating tumor cells in the blood of patients with muscle invasive bladder cancer prior to radical cystectomy. Poster presented at SIU World Uro-Oncology Meeting, Santiago, Chile, Nov. 2008.
  13. Guzzo TJ, Bivalacqua TJ, Schoenberg MP. Bladder cancer and the aluminum industry: A review of the current literature. Poster presented at SIU World Uro-Oncology Meeting, Santiago, Chile, Nov. 2008.
  14. Guzzo TJ, Schaeffer EM, Matlaga B, Pavlovich CP, Allaf ME. Laparoscopic radical nephrectomy for patients with pathologic T3b renal cell carcinoma: The Johns Hopkins experience. Poster presented at WCE Annual Meeting, Shanghai, China, Dec. 2008.
  15. Guzzo TJ, Pollock R, Matlaga B, Allaf ME. CT-guided percutaneous cryoablation of renal masses performed by a urologist: Safety, efficacy, and learning curve implications. Poster presented at WCE Annual Meeting, Shanghai, China, Dec. 2008.
  16. Guzzo TJ, Pollock R, Matlaga B, Gonzalgo ML, Allaf ME. Laparoscopic retroperitoneal lymph node dissection with therapeutic intent: Perioperative outcomes and early oncological results. Poster presented at WCE Annual Meeting, Shanghai, China, Dec. 2008.
  17. Guzzo TJ, Schaeffer EM, Matlaga B, Allaf ME. Laparoscopic radical nephrectomy and regional lymph node dissection for renal cell carcinoma with renal vein thrombus. Video presented at WCE Annual Meeting, Shanghai, China, Dec. 2008.
  18. Guzzo TJ, Schaeffer EM, Allaf ME. Laparoscopic radical nephroureterectomy with en-bloc distal ureteral and bladder cuff excision using a single positioning pneumovesicum method. Video presented at WCE Annual Meeting, Shanghai, China, Dec. 2008.
  19. Guzzo TJ, Ross AE, Bivalacqua TJ, Matlaga B, Allaf ME. Robotic-assisted appendiceal interposition for the management of a long proximal ureteral stricture. Video presented at WCE Annual Meeting, Shanghai, China, Dec. 2008.
  20. Guzzo TJ, Magheli A, Bivalacqua TJ, Schoenberg MP, Gonzalgo ME. The impact of tumor upstaging at the time of radical cystectomy for patients with high grade non-muscle invasive urothelial carcinoma. Poster presented at AUA National Meeting, Chicago, IL, Apr. 2009.
  21. Guzzo TJ, Reddy S, Schaeffer EM, Wolfgang CL, Allaf ME. Outcomes of patients following pancreatic resection for isolated renal cell carcinoma metastasis. Poster presented at AUA National Meeting, Chicago, IL, Apr. 2009.
  22. Resnick MJ, Canter DJ, Guzzo TJ, Brucker BM, Bergey M, Sonnad S, Wein AJ and Malkowicz SB: Defining pathologic parameters to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: implications for adjuvant radiation therapy? Abstract presented at AUA National Meeting, Chicago, IL, Apr. 2009.
  23. Pierorazio PM, Guzzo TJ, Han M, Bivalacqua TJ, Epstein JI, Schoenberg MP, Walsh PC and Partin AW: Long-term survival after radical prostatectomy for men with high pathologic gleason sum. Abstract presented at AUA National Meeting, Chicago, IL, Apr. 2009.
  24. Magheli A, Pavlovich C, Su LM, Guzzo TJ, Netto G, Humphreys E, Han M, Partin AW and Gonzalgo ML: Impact of surgical technique (open vs. laparoscopic vs. robotic-assisted) on pathologic and biochemical outcomes following radical prostatectomy: an analysis utilizing propensity score matching. Poster presented at the Mid-Atlantic AUA Section Meeting, Williamsburg, VA, Oct. 2009.
  25. Resnick MJ, Guzzo TJ, Canter DJ, Bivalacqua TJ, Tomaszewski JE, Wein AJ and Malkowicz SB: Endorectal MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for expectant management. Resident prize essay contest, Mid-Atlantic AUA Section Meeting, Williamsburg, VA, Oct. 2009.
  26. Mucksavage P, Mucksavage M, Kutikov A, White S, Guzzo TJ, VanArsdalen K, Malkowicz SB: Magnetic resonance imaging better predicts pathologic renal tumor size prior to radical or partial nephrectomy. Resident prize essay contest, Mid-Atlantic AUA Section Meeting, Williamsburg, VA, Oct. 2009.
  27. Resnick MJ, Canter DJ, Guzzo TJ, Magerfleisch L and Malkowicz SB: Does the yield of random bladder biopsies justify their use in the assessment of patients following intravesical BCG therapy? Resident prize essay contest, Mid-Atlantic AUA Section Meeting, Williamsburg, VA, Oct. 2009.
  28. Han M, Trock B, Partin AW, Humphreys E, Bivalacqua TJ, Guzzo TJ and Walsh PC: The impact of preoperative erectile dysfunction on survival after radical prostatectomy. Abstract presented at Mid-Atlantic AUA Section Meeting, Williamsburg, VA, Oct. 2009.
  29. Guzzo TJ, McNeil BK, Bivalacqua TJ, Elliott DJ, Sokoll LJ and Schoenberg MP: The presence of circulating tumor cells does not predict extravesical disease in bladder cancer patients prior to radical cystectomy. Poster presented at the Society of Urologic Oncology National Meeting, Bethesda MD, December 2009.
  30. Resnick MJ, Lee D, Wein AJ, Vanarsdalen K, Malkowicz SB and Guzzo TJ: Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer. Abstract presented at Philadelphia Urologic Society Resident’s Night Competition, Philadelphia PA, March 2010.
  31. Balandra A, Mucksavage P, Bergey M, Magerfliesch L, Wein AJ, Guzzo TJ and Malkowicz SB: ABO blood group characterization provides no stratification of pathologic findings or biochemical free survival in radical prostatectomy patients. Abstract presented at Philadelphia Urologic Society Resident’s Night Competition, Philadelphia PA, March 2010.
  32. Resnick M, Lee DJ, VanArsdalen K, Wein AJ, Malkowicz SB and Guzzo TJ: Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer. Abstract presented at AUA National Meeting, San Francisco, CA, May 2010.
  33. Stansell L, Newman D, Magerfleish L, Wein AJ, Guzzo TJ and Malkowicz SB: Increased basal resting tone during EMG biofeedback is associated with improved voiding for patients with orthotopic neobladder dysfunction. Abstract presented at AUA National Meeting, San Francisco, CA, May 2010.
  34. Yeboa DN, Liao K, Guzzo TJ, Haas NB, Christodouleas JP, Vapiwala N, Sunderland R, Mitra N, Armstrong K and Bekelman JE: PSA surveillance in men with localized prostate cancer. Abstract presented at ASCO Annual Meeting, Chicago, IL, June 2010.
  35. White SE, Guzzo TJ, Spence AM, VanArsdalen KN, Wein AJ and Malkowicz SB: Body mass index is not associated with lower recurrence free survival in patients with non-muscle invasive bladder cancer treated with Bacillus Calmette-Guerin. Abstract presented at Mid-Atlantic AUA Section Meeting, Farmington, PA, Sept. 2010.
  36. Guzzo TJ, Pierorazio P and Allaf ME: Laparoscopic retroperitoneal lymph node dissection with therapeutic intent in men with clinical stage one nonseminomatous germ cell tumors. Abstract presented at Mid-Atlantic AUA Section Meeting, Farmington, PA, Sept. 2010.
  37. Swisher-McClure SD, Sunderland, Christodouleas J, Guzzo TJ, Haas N, Vapiwala N and Bekelman J: Variation in use of androgen suppression with external beam radiotherapy for non-metastatic prostate cancer. Abstract presented at ASCO National Meeting, San Diego, CA, Oct. 2010.
  38. Resnick, MJ, Bergey M, Magerfleisch L, Tomaszewski JE, Malkowicz SB and Guzzo TJ: Longitudinal evaluation of the concordance and prognostic value of lymphovascular invasion in transurethral resection and radical cystectomy. Abstract presented at the Society of Urologic Oncology National Meeting, Bethesda MD, Dec. 2010.
  39. Guzzo TJ, Hockenberry MS, Mucksavage P, Bivalacqua TJ and Schoenberg MP: Smoking knowledge assessment and cessation trends in patients with bladder cancer presenting to a tertiary referral center. Abstract presented at Mid-Atlantic AUA Section Meeting, Orlando FL, Oct 2011.
Editorials, Chapters, Participation in Committee Reports (print or other media)
  1. Guzzo TJ, Malkowicz SB. Retroperitoneal diseases. Chap. 18 in Hanno PM, Wein AJ, Malkowicz SB, eds.: Penn Clinical Manual of Urology. Philadelphia: Elsevier, 2007, 653-664.
  2. Guzzo TJ, Vira MA, Dey W, Hwang WT, Tomaszewski J, Van Arsdalen K, Wein AJ, Malkowicz B. Re: Guzzo TJ, Vira MA, Neway W, et al: Minimal tumor volume may provide additional prognostic information in good performance patients after radical prostatectomy. Urology 69: 1147-1151, 2007. [Commentary] Urology 71(6):1230-1231, June 2008.
  3. Guzzo TJ, Gonzalgo ML. Addictions in malignancy. Chap. 20 in Miller N, eds.: Addictions in Medicine: Principles and Practice. New York: John Wiley & Sons, 2009 (in press).
  4. Guzzo TJ. Be prepared: side-effects of treatment. Chap 4 in Gonzalgo ML, eds: The Johns Hopkins Guide for Patients with Bladder Cancer. The Johns Hopkins University Press, 2009 (in press).
  5. Guzzo TJ. Take action: comprehensive treatment considerations. Chapter 3 in Gonzalgo ML, eds: The Johns Hopkins Guide for Patients with Bladder Cancer. The Johns Hopkins University Press, 2009 (in press).
  6. Guzzo TJ and Gonzalgo ML: The impact of discordance between biopsy and pathologic Gleason scores on survival after radical prostatectomy. [Editorial Comment] Journal of Urology 181: 104, 2009.
  7. Guzzo TJ and Gonzalgo ML: Toward image guided robotic surgery: system validation. [Editorial Comment] Journal of Urology 181: 789-790, 2009.
  8. Guzzo TJ: Lymphovascular invasion is an independent predictor of oncological outcomes in patients with lymph node-negative urothelial bladder cancer treated by radical cystectomy: a multicentre validation trial. [Editorial Comment] British Journal of Urology (In Press).
  9. Guzzo TJ and Allaf ME: Laparoscopic retroperitoneal lymph node dissection. Chap. in
    Smith A, Tanagho EA and McAnich JW: Smith’s General Urology.
  10. Resnick MJ and Guzzo TJ: Patient selection essential in optimizing benefit of radical
    prostatectomy for patients with organ-confined prostate cancer. Asian Journal of Andrology (In
    press)
Alternative Media
  1. Guzzo TJ: Robotic-assisted laparoscopic radical prostatectomy. Video made for and appears on The Oncology Nursing Society Prostate Cancer Webcourse. 2010
  2. Guzzo TJ: Prostate Cancer. MD Consult, Online addition.
  3. Guzzo TJ: What’s new in muscle invasive bladder cancer. Radio interview, Reach MD, Satellite Radio. May 2011

Dr. Thomas Guzzo

 
footer Terms of Use Legal Disclaimer Site Map Contact Us Financial Assistance About Penn Medicine Privacy Statement
penn medicine